← Leaderboards
Mack Su
Harvard Medical School
$88,259
Attributed
$88,259
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2018–19$100K$75K$50K$25K$0
'18
'19
Funding mix
By agency
NIH$88,259 · 1
By mechanism
F30$88,259 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Marie-Claire Elisabeth Gauduin$15,247,447
- Dennis L. Kasper$33,539,979
- Arlene H Sharpe$68,359,602
- Elliot Hideki Akama-Garren$125,164
- Elizabeth A White$5,103,815
Others in their field
Other Emerging Leaders on “Antigens”
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$42,191,190
- Bala Raja · Luminostics, Inc.$28,624,460
- Hanjoon Ryu$28,519,898
- Thomas Denny · Duke University$22,999,550
- Jay Evans · University Of Montana$22,565,626
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
Research focus
AntigensAntitumor EffectAnti-Tumor Immune ResponseAutoantigensAutoimmune ProcessAutoimmune ResponsesBaseBilateralCancer ImmunotherapyCancer ModelCancer PatientCancer TypeCd8-Positive T-LymphocytesCellsChronicClinical DevelopmentClinical TrialsDna DamageDna Sequence AlterationEnvironmental CarcinogensEpidermisEpitopesEpitope SpreadingAllergic Contact Dermatitis
Grant awards (2)
The role of UV-induced neoantigens and exogenous neoepitopes in enhancing response to immune checkpoint blockade in melanoma and other cancers.$50,016
F30 · FY2019 · ES · contact PI
The role of UV-induced neoantigens and exogenous neoepitopes in enhancing response to immune checkpoint blockade in melanoma and other cancers.$38,243
F30 · FY2018 · ES · contact PI